Cal-Maine Foodsの空売り状況は、投資家がCal-Maine Foodsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Cal-Maine Foods (NASDAQ:CALM) 株価情報, 空売り情報

Cal-Maine Foods

Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.

Cal-Maine Foods Inc

Calmare Therapeutics Inc

As of Nov. 20, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Energizer Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>)</h3>
<ul>
<li>On Nov. 19, Energizer Holdings reported better-than-expected fourth-quarter adjusted EPS results. &#8220;We finished fiscal 2024 with solid performances across both Battery and Auto Care, driving adjusted earnings growth above our initial expectations,&#8221; said Mark LaVigne, President and Chief Executive Officer. The company's stock gained around 15% over the past month and has a <a href="https://www.benzinga.com/quote/ENR">52-week high of $39.21</a>.</li>
<li>RSI Value: 88.06&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ENR Price Action: Shares of Energizer gained 9.1% to close at $37.25 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Freshpet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>)</h3>
<ul>
<li>On Nov. 4, Freshpet reported better-than-expected third-quarter financial results and raised its full-year adjusted EBITDA outlook. &#8220;Our third quarter results demonstrate the strength and consistency of both net sales and profitability growth we have been striving to deliver. We delivered our 25th consecutive quarter of >25% year on year net sales growth and matched that with a very strong operating performance. This further strengthens our confidence in our ability to meet or exceed our 2027 goals,&#8221; commented Billy Cyr, Freshpet&#8217;s Chief Executive Officer. The company's stock gained around 14% over the past month and <a href="https://www.benzinga.com/quote/FRPT">has a 52-week high</a> of $159.12.</li>
<li>RSI Value: 72.43</li>
<li>FRPT Price Action: Shares of Freshpet gained 3.9% to close at $156.38 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Cal-Maine Foods Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>On Oct. 1, the company posted better-than-expected quarterly earnings. Sherman Miller, president and chief executive officer of Cal-Maine Foods, stated, &#8220;Our financial and operating results for the first quarter mark a strong start to fiscal 2025 for Cal-Maine Foods. These results reflect favorable demand for shell eggs during most of the quarter and significantly higher market prices compared with the first quarter last year.&#8221; The company's stock gained around 4% over the past month and has a <a href="https://www.benzinga.com/quote/CALM">52-week high</a> of $96.02.</li>
<li>RSI Value: 70.14</li>
<li>CALM Price Action: Shares of Cal-Maine gained 1.3% to close at $95.14 on Tuesday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42069785/wall-streets-most-accurate-analysts-weigh-in-on-3-defensive-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 5% Dividend Yields</a></li>
</ul>

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

CALM

FRPT

Top 3 Risk Off Stocks That May Collapse This Quarter

Company Updates Progress on Dexter, Missouri Conversion
Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) today announced that on October 4, 2024, its Board of Directors approved $40 million in new capital projects to further expand the Company's cage-free production capabilities. The Company plans to fund the projects through a combination of available cash on hand, sales of investment securities and operating cash flow.
The projects will include the addition of five new cage-free layer houses across the Company's locations in Florida, Georgia, Utah and Texas. The Company plans to start construction by the end of calendar 2024 and expects the projects to be completed with additional production capacity for approximately 1.0 million cage-free layer hens by late summer 2025. These additions will primarily replace recently retired caged facilities and add to the Company's cage-free capacity.
The Company also provided an update on its conversion of the former Tyson Foods facilities in Dexter, Missouri, acquired on March 14, 2024. Following the closing, the Company began work to remodel and repurpose these assets for use in shell egg production. Cal-Maine Foods has also been working with local contract growers and has commitments that would result in approximately 1.2 million additional free-range hens by fall 2025, with plans to add more capacity in the future.

Cal-Maine Foods Approved $40M In New Capital Projects To Further Expand  Plans For Additional Cage-Free Production Capabilities

As of Oct. 7, 2024, two stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Cal-Maine Foods Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>On Oct. 1, Cal-Maine Foods posted better-than-expected quarterly earnings. Sherman Miller, president and chief executive officer of Cal-Maine Foods, stated, &#8220;Our financial and operating results for the first quarter mark a strong start to fiscal 2025 for Cal-Maine Foods. These results reflect favorable demand for shell eggs during most of the quarter and significantly higher market prices compared with the first quarter last year. At the same time, the national egg supply has declined due to the recent outbreaks of highly pathogenic avian influenza (&#8220;HPAI&#8221;).&#8221; The company's stock gained around 24% over the past month and has a w<a href="https://www.benzinga.com/quote/CALM">eek high of $84.67</a>.</li>
<li>RSI Value: 85.31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>CALM Price Action: Shares of Cal-Maine gained 6.2% to close at $84.57 on Friday.</li>
</ul>
<h3 class="wp-block-heading">BJ&#8217;s Wholesale Club Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>)</h3>
<ul>
<li>On Sept. 23, Melius Research analyst Karen Short initiated coverage on BJ&#8217;s Wholesale Club with a Buy rating and announced a price target of $90. The company's stock gained around 11% over the past month and <a href="https://www.benzinga.com/quote/BJ">has a 52-week high</a> of $92.37.</li>
<li>RSI Value: 70.08</li>
<li>BJ Price Action: Shares of BJ&#8217;s Wholesale rose 1% to close at $86.50 on Friday.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41196046/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yiel">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a></li>
</ul>

Top 2 Defensive Stocks That May Crash In October

Stephens &amp; Co. analyst Pooran Sharma reinstates Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) with a Equal-Weight and announces $82 price target.

Price Target

Initiation

Analyst Ratings

Stephens & Co. Reinstates Equal-Weight on Cal-Maine Foods, Announces $82 Price Target

Dividend Payment
For the fourth quarter of fiscal 2024, Cal-Maine Foods will pay a cash dividend of approximately $1.02 per share to holders of its Common Stock and Class A Common Stock. Pursuant to Cal-Maine Foods' variable dividend policy, for each quarter in which the Company reports net income, the Company pays a cash dividend to shareholders in an amount equal to one-third of such quarterly income. Following a quarter for which the Company does not report net income, the Company will not pay a dividend with respect to that quarter or for a subsequent profitable quarter until the Company is profitable on a cumulative basis computed from the date of the most recent quarter for which a dividend was paid. The amount paid per share will vary based on the number of outstanding shares on the record date. The dividend is payable on November 14, 2024, to holders of record on October 30, 2024.

Dividends

Cal-Maine Foods Will Pay A Cash Dividend Of ~$1.02 Per Share To Holders Of Its Common Stock And Class A Common Stock

Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) reported quarterly earnings of $3.06 per share which beat the analyst consensus estimate of $2.33 by 31.33 percent. This is a 15200 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $785.87 million which beat the analyst consensus estimate of $614.77 million by 27.83 percent. This is a 71.09 percent increase over sales of $459.34 million the same period last year.

Earnings

Earnings Beats

Cal-Maine Foods Q1 EPS $3.06 Beats $2.33 Estimate, Sales $785.87M Beat $614.77M Estimate

Stocks are gearing up for another nervy start on Tuesday after they scrapped through in the previous session to<a href="https://www.benzinga.com/news/earnings/24/10/41110228/s-p-records-first-positive-september-since-2019-amid-improving-investor-sentiment-fear-index-moves-"> finish a seasonally weak September on a high.</a> Some strategists point to the unusual September gains as a testament to the market&#8217;s resilience. The unequivocal belief is the gains could continue into the fourth quarter and beyond only if the economy can skirt a recession.
Each incoming economic data, including the job opening and manufacturing activity data due Tuesday, would offer evidence regarding the economy&#8217;s strength or lack thereof. This being the presidential election year, traders brace for more volatility at least until Nov. 5. The market may also have to contend with earnings as they begin to roll out in the second half of the month.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>+0.07%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.09%</td>
</tr>
<tr>
<td>Dow</td>
<td>-0.27%</td>
</tr>
<tr>
<td>R2K</td>
<td>-0.23%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Tuesday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) eased 0.02% to $573.63 and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.09% to $488.50, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Week:
U.S. stocks survived a bout of selling pressure and closed Monday&#8217;s session higher. The overbought levels and a slump in some major global markets introduced caution right at the start of the session, and the major indices moved mostly below the unchanged line for much of the session. The selling intensified after Fed Chair Jerome Powell poured cold water on hopes of rapid downward adjustment of rates during his speech.
The major indices staged a late-hour recovery to end September firmly in the green, with the S&amp;P 500 and Dow Industrials closing at fresh highs. Nine of the 11 S&amp;P 500 sector classes closed in the green, with communication services, energy and real estate stocks seeing strong buying interest. On the other hand, material and consumer discretionary stocks pulled back.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Day&#8217;s Performance (+/)</td>
<td>Value</td>
<td>September Performance</td>
<td>Q3 Performance</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>+0.38%</td>
<td>18,189.17</td>
<td>+2.69%</td>
<td>+2.58%</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>+0.42%</td>
<td>5,762.48</td>
<td>+2.02%</td>
<td>+5.53%</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>+0.04%</td>
<td>42,330.15</td>
<td>+1.85%</td>
<td>+8.21%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>+0.24%</td>
<td>2,229.97</td>
<td>+0.56%</td>
<td>+8.90%</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Fed&#8217;s larger-than-expected rate cut can buy more time for high-quality stocks to remain expensive and even help lower-quality cyclical stocks, especially after recent China actions, said Morgan Stanley&#8217;s US Equity Strategist Mike Wilson. &#8220;However, I believe labor data and other growth indicators need to improve to justify these conditions continuing into year-end and beyond – i.e., a soft landing with growth reaccelerating, inflation stabilizing above 2%, and the Fed continuing to cut rates, &#8221; the strategist said.
The market is entering a seasonally strong period after being up for eight of the nine months. Fund Strat&#8217;s Head of Research Tom Lee said in the firm&#8217;s weekly commentary that the following three favorable structural drivers for equities support &#8220;buy the dip:&#8221;
<ul>
<li>Fed launches easing cycle + &#8220;no landing&#8221;</li>
<li>China PBOC bazooka</li>
<li>Post-election and cash on sidelines dynamics</li>
</ul>
He noted that when the Fed cuts rate and the US economy is not in recession, the S&amp;P 500 Index has risen seven out of seven times both three and six months later.
See also: <a href="https://www.benzinga.com/money/best-futures-trading-software">Best Futures Trading Software</a>
Upcoming Economic Data:
<ul>
<li>S&amp;P Global is due to release the final manufacturing purchasing managers&#8217; index for September at 9:45 a.m. EDT. Economists, on average, expect the final manufacturing PMI to come in at 47, down from 47.9 in August.</li>
<li>The Institute for Supply Management will release its national manufacturing PMI at 10 a.m. EDT, with the consensus calling for a reading of 47.5 for September, slightly up from 47.2 in August.</li>
<li>The Labor Department is scheduled to release the results of its August Job Openings and Labor Turnover Survey at 10 a.m. EDT. Economists, on average, estimate job openings to remain unchanged with the July level, at 7.7 million.</li>
<li>The Commerce Department&#8217;s construction spending report for August, due at 10 a.m. EDT, will likely show flattish spending relative to July, which saw a 0.3% month-over-month drop.</li>
<li>Federal Reserve Governor Lisa Cook will make a public appearance at 11:10 a.m. EDT.</li>
<li>Richmond Fed President Tom Barkin, Atlanta Fed President Raphael Bostic and Boston Fed President Susan Collins are scheduled to participate in a joint panel discussion about technology-enabled&nbsp;disruption at 6:15 p.m. EDT.</li>
</ul>
Stocks In Focus:
<ul>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) rallied nearly 7.50% <a href="https://www.benzinga.com/premarket">in premarket trading </a>after the company said it has expanded its TV streaming delivery network to multi-site operation.</li>
<li>Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) climbed over 2% on a positive analyst action.</li>
<li>Acuity Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>), McCormick &amp; Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>), Paychex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) and United Natural Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) are among the notable <a href="https://www.benzinga.com/calendars/earnings">companies due to report their quarterly results before the market open.</a></li>
<li>Those reporting after the close are NIKE, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), Resources Connection, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGP#NASDAQ">RGP</a>) and Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>).</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures pulled back sharply, while gold futures advanced moderately. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) traded slightly higher under the $64K level. The yield on the 10-year benchmark Treasury note fell 5.7 basis points to 3.745%.
In Asia, the Japanese market rebounded, although sentiment elsewhere remained muted. The Chinese, Hong Kong and South Korean markets remained closed for public holidays. European stocks showed tentativeness in early trading ad traders digested the preliminary September consumer price inflation data for the eurozone.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41111098/if-you-invested-1-000-in-peter-thiel-co-founded-palantir-when-it-ipoed-4-years-ago-heres-how-muc">If You Invested $1,000 In Peter Thiel Co-founded Palantir When It IPOed 4 Years Ago, Here&#8217;s How Much You Would Have Now</a></li>
</ul>
Image Via Shutterstock

Equities

Previews

Economics

Federal Reserve

Movers

$BTC

PAYX

UNFI

US Stocks Set For Shaky Start Ahead Of JOLTS Data, Nike Earnings: Strategist Says These 3 Structural Drivers Support 'Buying The Dip'

Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) today announced that it has completed a strategic investment with Crepini LLC, establishing a new egg products and prepared foods joint venture. Crepini LLC, founded in 2007, has grown its brand throughout the United States and Mexico featuring egg wraps, protein pancakes, crepes, and wrap-ups, which are now sold online and in over 3,500 retail stores.
The new entity, located in Hopewell Junction, New York, will operate as Crepini Foods LLC ("Crepini"). Cal-Maine Foods will capitalize Crepini with approximately $6.75 million in cash to purchase additional equipment and other assets and fund working capital in exchange for a 51% interest in the new venture. Crepini LLC will contribute its existing assets and business in exchange for a 49% interest in the new venture.

Contracts

Cal-Maine Foods Has Completed A Strategic Investment With Crepini, Establishing A New Egg Products And Prepared Foods Joint Venture; The New Entity, Will Operate As Crepini Foods. Cal-Maine Foods Will Capitalize Crepini With ~$6.75M In Cash To Purchase Additional Equipment And Other Assets And Fund Working Capital In Exchange For A 51% Interest In The New Venture

Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) reported quarterly earnings of $2.32 per share which beat the analyst consensus estimate of $1.85 by 25.41 percent. The company reported quarterly sales of $640.80 million which beat the analyst consensus estimate of $608.66 million by 5.28 percent. This is a 6.95 percent decrease over sales of $688.68 million the same period last year.

Cal-Maine Foods Q4 2024 Adj EPS $2.32 Beats $1.85 Estimate, Sales $640.80M Beat $608.66M Estimate

Goldman Sachs analyst Adam Samuelson maintains Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) with a Sell and raises the price target from $47 to $52.

Goldman Sachs Maintains Sell on Cal-Maine Foods, Raises Price Target to $52

U.S. stocks were mixed, with the Dow Jones index gaining around 150 points on Wednesday.
Shares of U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) shares rose during Wednesday's session following a <a href="https://www.benzinga.com/news/earnings/24/07/39813946/us-bancorp-q2-earnings-net-interest-income-dips-but-fee-income-grows">second-quarter earnings beat</a>.
Revenue stood at $6.867 billion (-4.3% Y/Y), beating the consensus of $6.795 billion. Adjusted earnings per share totaled 98 cents, beating the consensus of 94 cents, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
U.S. Bancorp shares gained 4.7% to $45.34 on Wednesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) shares jumped 16.4% to $19.60 after the company reported better-than-expected Q4 financial results and issued FY25 revenue guidance above estimates. Also, the company announced it entered into a stock purchase agreement and made $12.7 million in orders for its FOX WaferPak full wafer Contractors.</li>
<li>The Honest Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNST#NASDAQ">HNST</a>) shares rose 14% to $4.0350.</li>
<li>GLOBALFOUNDRIES Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) surged 12.7% to $61.36.</li>
<li>Stardust Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) rose 11.1% to $11.11.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) gained 9.4% to $16.50 after the company announced a strategic partnership with CoreWeave.</li>
<li>fuboTV Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) gained 9.1% to $1.5610</li>
<li>GitLab Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) shares climbed 8.4% to $54.92 following a report suggesting the company is exploring a sale.</li>
<li>SunCar Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>) rose 8.2% to $9.14.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) gained 8% to $16.27 after the company announced a strategic partnership with CoreWeave.</li>
<li>V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) rose 7.8% to $15.35 after the company announced it entered into a Stock and Asset Purchase Agreement to sell its Supreme brand to EssilorLuxottica for $1.5 billion in cash.</li>
<li>Nicolet Bankshares, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIC#NYSE">NIC</a>) surged 7.4% to $100.14 following upbeat quarterly earnings.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ: CALM) shares rose 5.6% to $67.93. Cal-Maine Foods is scheduled to release its fourth quarter and fiscal 2024 financial results on Tuesday, July 23.</li>
<li>UTime Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) gained 5.5% to $1.0262.</li>
<li>Hancock Whitney Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>) rose 5.3% to $56.51 following upbeat second-quarter results.</li>
<li>Bristol-Myers Squibb Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) gained 5.2% to $43.40.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39814468/alphabet-crowdstrike-and-2-other-stocks-insiders-are-selling">Alphabet, CrowdStrike And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

Intraday Update

AEHR

FUBO

GTLB

HNST

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SDST

US Bancorp Posts Upbeat Earnings, Joins Aehr Test Systems, Hancock Whitney And Other Big Stocks Moving Higher On Wednesday

Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) (&quot;Cal-Maine Foods&quot; or the &quot;Company&quot;) today announced the Company has completed the acquisition of substantially all the assets of ISE America, Inc. and certain affiliates (&quot;ISE&quot;) for approximately&nbsp;$110 million. Cal-Maine Foods is funding the acquisition with available cash on hand. The acquired ISE assets include commercial shell egg production and processing facilities with current capacity of approximately 4.7 million laying hens, including 1.0 million cage-free, and 1.2 million pullets, feed mills, approximately 4,000 acres of land, inventories and an egg products breaking facility. The acquired assets also include an extensive customer distribution network across the Northeast and Mid-Atlantic states, and production operations in Maryland, New Jersey, Delaware and South Carolina.

Cal-Maine Foods Acquires ISE America Assets for $110M, Expands Production Capacity

For consumers already dealing with sticky inflation, one food staple is unlikely to provide relief for a uniquely concerning reason.
At the end of April, egg prices increased by 16% since January due to a spike in bird flu among chickens, impacting facilities at Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>).
Over the past three years, nearly 91 million birds have tested positive for bird flu. Adding to this concern, less than two months ago, scientists confirmed bird flu could also be found in cattle.&nbsp;
Don't Miss:
<ul>
<li>A<a href="https://www.benzinga.com/money/overplay"> startup that turns videos into games gets backing from Mark Cuban</a> and opens a round for regular investors at $250.</li>
<li>Elon Musk and Jeff Bezos are bullish on one city that could dethrone New York and become the new financial capital of the US.<a href="https://www.benzinga.com/money/miami-take-new-yorks-place-financial-capital"> Investing in its booming real estate market has never been more accessible</a>.</li>
</ul>
Dr. Lars Larsen, a veterinary microbiologist at the University of Copenhagen, explained the significance of the findings: "We see an enormous amount of virus in the mammary glands and in the milk" compared to other mammals.
Even more concerning, scientists recently confirmed that cows have human flu receptors, which could act as a "mixing vessel" for different virus mutations.
A co-study by scientists at the University of Copenhagen and St. Jude Children's Research Hospital in Memphis wrote that "these results provide a mechanistic rationale for the high levels of H5N1 virus reported in infected bovine milk and show cattle have the potential to act as a mixing vessel for novel [influenza virus] generation."
Trending: Warren Buffett flipped his neighbor's $67,000 life savings into a $50 million fortune —<a href="https://www.benzinga.com/money/advisor-adv-warren-buffett"> How much is that worth today?</a>
While the CDC maintains that the "risk to the general public remains low" and that human-to-human transmission remains "rare," the spread in cattle has already affected humans, with 70 dairy farmworkers in Colorado currently undergoing monitoring for possible symptoms of bird flu.&nbsp;
The CDC&#8217;s concern about a potential outbreak of bird flu <a href="https://www.benzinga.com/general/24/04/38220057/bill-gates-called-for-a-universal-flu-vaccine-now-the-cdc-director-says-the-organization-is-activate">remains at the top of the mind</a>, but a core issue for the agency now is to get the public to listen to it.
While the CDC has strongly advised against consuming raw milk due to the increase of bird flu among cows, warning that "raw milk can be contaminated with harmful germs that can make you very sick," the sale of unpasteurized milk has not reduced.&nbsp;
According to market research firm NielsenIQ, sales of raw milk have increased between 21% and 65% since March 25, when bird flu was first confirmed in cattle.&nbsp;
Keep Reading:
<ul>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." These<a href="https://www.benzinga.com/real-estate/23/05/32554601/want-to-grow-your-wealth-passively-these-high-yield-real-estate-notes-might-be-your-holy-grail"> high-yield real estate notes that pay 7.5% &#8211; 9%</a> make earning passive income easier than ever.</li>
<li><a href="https://www.benzinga.com/money/are-you-rich-advisor">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>

General

After 91 Million Birds Infected With Bird Flu In 3 Years, New Findings On Cows Raise Concerns: 70 Workers Monitored For Symptoms

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>. 
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>Dividend Yield: 3.30%</li>
<li>Stephens &amp; Co. analyst Ben Beinvenu reiterated an Equal-Weight rating with a price target of $65 on April 3, 2024. This analyst has an accuracy rate of 75%.</li>
<li>Goldman Sachs analyst Adam Samuelson maintained a Sell rating and increased the price target from $42 to $47 on March 12, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On April 4, Cal-Maine Foods said Jeff Hardin, Senior Vice President of Sales, is retiring from his position with the Company, effective July 23, 2024.</li>
</ul>
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul>
<li>Dividend Yield: 9.01%</li>
<li>Stifel analyst Matthew Smithreiterated a Buy rating with a price target of $50 on March 25. This analyst has an accuracy rate of 64%.</li>
<li>Morgan Stanley analyst Pamela Kaufman reiterated an Equal-Weight rating with a price target of $45 on July 18, 2023. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: On April 25, Altria Group reported a first-quarter FY24 sales decline of 2.5% year-on-year to $5.58 billion, beating the analyst consensus estimate of $4.71 billion.</li>
</ul>
<h3 class="wp-block-heading">Walgreens Boots Alliance, Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)</h3>
<ul>
<li>Dividend Yield: 5.79%</li>
<li>UBS analyst Kevin Caliendomaintained a Neutral rating and cut the price target from $25 to $22 on April 3. This analyst has an accuracy rate of 74%.</li>
<li>Morgan Stanley analyst Erin Wright maintained an Underweight rating and lowered the price target from $21 to $20 on April 1. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On April 24, DoorDash and Walgreens announced a new collaboration to offer SNAP/EBT payment at nearly 7,800 Walgreens stores across the country.</li>
</ul>
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38663466/over-10m-bet-on-sensata-technologies-check-out-these-4-stocks-insiders-are-buying">Over $10M Bet On Sensata Technologies? Check Out These 4 Stocks Insiders Are Buying</a>

Wall Street's Most Accurate Analysts' Views On 3 Risk Off Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a &lt;a href=&#8221;https://www.benzinga.com/yield-investments&#8221;&gt;&lt;em&gt; high dividend payout. &lt;/em&gt;&lt;/a&gt;
Benzinga readers can review the latest analyst takes on their favorite stocks&amp;nbsp;by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga&#8217;s extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>Dividend Yield: 3.13%</li>
<li>Stephens &amp; Co. analyst Ben Beinvenu reiterated an Equal-Weight rating with a price target of $65 on April 3, 2024. This analyst has an accuracy rate of 74%.</li>
<li>Goldman Sachs analyst Adam Samuelson maintained a Sell rating and raised the price target from $42 to $47 on March 12, 2024. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On April 4, Cal-Maine Foods said Jeff Hardin, Senior Vice President of Sales, is retiring from his position with the Company, effective July 23, 2024.</li>
</ul>
<h3 class="wp-block-heading">Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>)</h3>
<ul>
<li>Dividend Yield: 5.55%</li>
<li>Morgan Stanley analyst Pamela Kaufman maintained an Overweight rating and cut the price target from $118 to $113 on Oct. 2, 2023. This analyst has an accuracy rate of 65%.</li>
<li>Barclays analyst Gaurav Jain maintained an Overweight rating and slashed the price target from $115 to $100 on Sept. 21, 2023. This analyst has an accuracy rate of 74%.</li>
<li>Recent News: Philip Morris International is expected to report first-quarter earnings on April 23, 2024.</li>
</ul>
<h3 class="wp-block-heading">The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>)</h3>
<ul>
<li>Dividend Yield: 4.23%</li>
<li>B of A Securities analyst Bryan Spillane maintained a Buy rating and raised the price target from $40 to $42 on April 15, 2024. This analyst has an accuracy rate of 65%.</li>
<li>Wells Fargo analyst Chris Carey maintained an Equal-Weight rating and cut the price target from $38 to $37 on Feb. 15, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Recent News: The Kraft Heinz Company is expected to release its first quarter 2024 financial results on May 1, 2024.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/earnings/24/04/38351344/brown-brown-likely-to-report-higher-q1-earnings-here-are-the-recent-forecast-changes-from-wall-stre">Brown &amp; Brown Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a>

Wall Street's Most Accurate Analysts' Views On 3 Defensive Stocks Delivering High-Dividend Yields

Cal-Maine Foods Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>) is the largest and leading producer and distributor of fresh shell eggs in the United States, with a 19% market share. Shareholders are rejoicing over its strong fiscal Q3 2024 earnings report and special $1.00 dividend. The company has staged a solid turnaround despite egg prices falling and the growing concerns over highly pathogenic avian influenza (HPAI).
Demand has remained stronger than ever, as reflected by its blockbuster earnings figures. Despite record volumes, the basic materials sector stock is still in value investing territory, with shares trading at just 11.15X earnings and 13.59X forward earnings. It competes with Post Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/post#NYSE">POST</a>) as one of the largest food service suppliers of egg products.
<h2>Avian Flu Impacts </h2>
Concerns over avian flu (h5n1) have been making headlines, with farm livestock and cattle getting infected and even human infections becoming a reality. The USDA reported nearly 15.7 million commercial layer hens and pullets were depopulated (terminated) between November 2023 and January 2024. Cal-Maine experienced an outbreak in its Kansas facility, resulting in 1.5 million laying hens and 240,000 pullets being depopulated.
On April 2, 2024, the company reported positive test results for avian flu at its Parmer County, Texas facility, resulting in depopulating 1.6 million egg-laying hens (adult female chickens) and 337,000 pullets (less than 1 year-old female chickens) or 3.6% of its total flock. Production at the facility has been temporarily halted.&nbsp;
Cal-Maine was impacted by the significant egg supply reduction. With recent outbreaks causing market prices to spike, the overall impact is still considered to not be severe according to the company.
<h2>Growing Portfolio of Brands</h2>
The company has continued to acquire farms like Fassio Egg Farms and a closed broiler processing plant, hatchery and feed mill from Tyson Foods Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tsn#NYSE">TSN</a>) to help meet the strong demand. While you may not have seen Cal-Maine namesake brand eggs at your local grocer, you&#39;ve more than likely purchased eggs under their portfolio of brands. They include Farmhouse, 4-Grain, Egg-Land&#39;s Best, Sunny Meadows and Land O&#39;Lakes.
<img alt="calm stock daily cup and handle breakout" src="https://www.marketbeat.com/logos/articles/med_20240407134930_chartz-calm.jpg" style="height:800px; width:915px" />
<h2>Daily Cup and Handle Breakout </h2>
The daily candlestick chart on CALM illustrates a cup and handle breakout pattern. The cup lip line formed on the double top at $58.31 on April 4, 2023. Shares sold off to a swing low of $42.16 on October 4, 2023, before staging a rally back towards the cup lip line, peaking at $57.83. CALM pulled back down to $52.91 on January 4, 2024, to set the stage for the handle formation as shares attempted twice to break the cup lip line, eventually reaching a new high peak at $64.76. The daily relative strength index (RSI) is testing the 70-band on its recent bounce. Pullback support levels are at $58.31, $55.11, $50.23 and $48.06.
<h2>Eggs-Citing EPS Beat and Special Dividend &nbsp;</h2>
On April 2, 2024, Cal-Maine reported an EPS of $3.00, beating consensus estimates for $2.45 by 55 cents. Revenues fell 29.5% YoY to $703.08 million, beating $692.35 million consensus estimates. The company will pay out a special $1.00 dividend to hold its Class A common stock, payable May 16, 2024, to holders of record as of May 1, 2024.
<h2>CEO Insights </h2>
Cal-Maine CEO Max Bowman noted that its fiscal Q3 2024 sales of $703.1 million were up against tough comps of $997.5 million in the year-ago period, which was the company&#39;s highest quarterly sales period with record high average selling prices for specialty and conventional eggs. The sales decline was a result of a significant drop in supplies due to the avian flu. Market prices have spiked as a result. Overall volume rose 3.2% to 300.9 million dozen.
Conventional eggs sold grew 2.6% to 192.2 million dozen, while specialty eggs rose 4.4% YoY to 108.6 million dozen sold. The net average selling price per dozen conventional eggs dropped 40% to $2.152 compared to $3.678 in the year-ago period. Specialty egg prices fell from $2.616 per dozen, down 36.1%, to $2.415 per dozen.
Bowman commented, &quot;Demand for shell eggs has remained strong as consumers look for an affordable and nutritious protein option. Across our operations, we are focused on meeting this demand as we continue to identify opportunities to extend our market reach.&quot;
Bowman concluded, &quot;We have a strong balance sheet that provides us with the flexibility to fund our growth initiatives, including potential acquisitions. We believe fiscal 2024 will be another successful year for the Company, and we look forward to the opportunities ahead for Cal-Maine Foods.&quot;
<a href="https://www.marketbeat.com/stocks/NASDAQ/CALM/price-target/">Cal-Maine analyst ratings and price targets</a> are at MarketBeat. Cal-Maine&#39;s peers and competitor stocks can be found with the <a href="https://marketbeat.com/stock-screener/">MarketBeat stock screener.</a>
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/cal-maine-foods-delivers-an-eggs-citing-eps-beat/">Cal-Maine Foods Delivers an Eggs-Citing EPS Beat</a>&quot; first appeared on MarketBeat.

POST

Cal-Maine Foods Delivers an Eggs-Citing EPS Beat

Shares of Ulta Beauty, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ulta#NASDAQ">ULTA</a>) fell sharply during Wednesday&rsquo;s session amid the company&#39;s presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook.
Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>ARCA biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abio#NASDAQ">ABIO</a>) climbed 108% to $3.5549 after the company and Oruka Therapeutics announced a merger agreement.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktra#NASDAQ">KTRA</a>) shares gained 89% to $0.1906 after the company entered a merger agreement with TuHURA Biosciences.</li>
<li>Next Technology Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtt#NASDAQ">NXTT</a>) rose 57.4% to $6.42.</li>
<li>Vanda Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnda#NASDAQ">VNDA</a>) shares climbed 39.3% to $5.45. Vanda Pharmaceuticals&#39; Fanapt&reg; received U.S. FDA approval for the acute treatment of Bipolar I Disorder.</li>
<li>VivoPower International PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvpr#NASDAQ">VVPR</a>) shares gained 39% to $8.20 after the company declared a capital management strategy including a stock buyback program of up to $5 million.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) gained 32.7% to $0.0345.</li>
<li>XTI Aerospace, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xtia#NASDAQ">XTIA</a>) rose 32.2% to $4.63. BestGrowthStocks.com issued comprehensive evaluation of XTI Aerospace, Inc.</li>
<li>Brooge Energy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brog#NASDAQ">BROG</a>) gained 28.8% to $3.0790.</li>
<li>Addex Therapeutics Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adxn#NASDAQ">ADXN</a>) rose 24.6% to $16.21 after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix.</li>
<li>Aesthetic Medical International Holdings Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aih#NASDAQ">AIH</a>) gained 24.3% to $0.3981 after gaining 13% on Tuesday.</li>
<li>LAMF Global Ventures Corp. I (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvc#NASDAQ">LGVC</a>) gained 22.7% to $13.21. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd.</li>
<li>Quhuo Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qh#NASDAQ">QH</a>) rose 21.7% to $0.6501 after reporting unaudited financial results for the second half and full year 2023.</li>
<li>Destiny Tech100 Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NYSE">DXYZ</a>) gained 21.4% to $25.77.</li>
<li>OneMedNet Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onmd#NASDAQ">ONMD</a>) gained 21.2% to $0.9600. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement of senior convertible notes.</li>
<li>CXApp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxai#NASDAQ">CXAI</a>) gained 20.5% to $5.40 following a massive rally to start the week. CXApp shares rallied more than 150% to start the week after the company announced a partnership with Alphabet&rsquo;s Google Cloud.</li>
<li>Clean Energy Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cety#NASDAQ">CETY</a>) climbed 20.5% to $1.63.</li>
<li>American Battery Technology Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abat#NASDAQ">ABAT</a>) rose 17.7% to $1.9301. American Battery Technology Company was awarded $20 million tax credit through competitive U.S. DOE process to advance its critical minerals battery recycling facility.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) shares rose 14.9% to $0.0470 after gaining 13% on Tuesday. On March 26, C3is reported a year-over-year increase in fourth-quarter financial results.</li>
<li>Pyxis Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pyxs#NASDAQ">PYXS</a>) gained 12.3% to $6.04.</li>
<li>Atai Life Sciences N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atai#NASDAQ">ATAI</a>) surged 11.4% to $2.08. Maxim Group analyst Jason McCarthy upgraded ATAI Life Sciences from Hold to Buy and announced a $6 price target.</li>
<li>Dave &amp; Buster&#39;s Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/play#NASDAQ">PLAY</a>) shares rose 10.2% to $68.22 after the company reported fourth quarter results.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) jumped 9.7% to $3.16.</li>
<li>Signet Jewelers Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sig#NYSE">SIG</a>) gained 9.2% to $103.80after the company raised its FY25 guidance.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivp#NASDAQ">IVP</a>) gained 9% to $0.0512. On Jan. 5, Inspire Veterinary Partners filed a prospectus related to up to a $5 million public offering.</li>
<li>Semtech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smtc#NASDAQ">SMTC</a>) gained 7.4% to $30.28.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>) climbed 6.8% to $62.88 after the company reported upbeat results for its fourth quarter.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Casa Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/casa#NASDAQ">CASA</a>) shares dipped 78.1% to $0.0563 after the Company filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court.</li>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) fell 61.9% to $0.4196 after the company filed for Chapter 11 bankruptcy. The company on Tuesday said it reached a real with Cantor Fitzgerald and RXR to become a private company.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) fell 44.5% to $0.0232 after the company announced pricing of a $1.5 million public offering of common stock.</li>
<li>GCT Semiconductor Holding, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gcts#NYSE">GCTS</a>) dipped 40% to $9.29 amid volatility following the company&#39;s recently completed business combination with Concord Acquisition Corp III and NYSE debut.</li>
<li>FibroGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fgen#NASDAQ">FGEN</a>) fell 32.8% to $1.4499. FibroGen announced topline data from the Fortis Therapeutics-sponsored Phase 1 study of FG-3246 (also known as FOR46), a potential first-in-class anti-CD46 antibody drug conjugate (ADC) with an MMAE-containing payload.</li>
<li>Keyarch Acquisition Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kych#NASDAQ">KYCH</a>) fell 28.5% to $9.65.</li>
<li>TRACON Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) dipped 24.2% to $0.3148 as the company issued an update on ongoing ENVASARC Phase 2 pivotal trial following Independent Data Monitoring Committee Recommendation to continue the trial as planned.</li>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) fell 22.5% to $0.9741 after dipping around 12% on Tuesday.</li>
<li>Anghami Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/angh#NASDAQ">ANGH</a>) fell 22.2% to $1.40. Anghami recently announced that it completed its transaction with OSN+.</li>
<li>Locafy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcfy#NASDAQ">LCFY</a>) dipped 21.9% to $3.67 following second-quarter results.</li>
<li>Vicinity Motor Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vev#NASDAQ">VEV</a>) fell 19.3% to $0.75 after the company reported a year-over-year decrease in fourth-quarter EPS results.</li>
<li>Enveric Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/envb#NASDAQ">ENVB</a>) dipped 18.4% to $0.93.</li>
<li>Murano Global Investments Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrno#NASDAQ">MRNO</a>) fell 16.8% to $10.39.</li>
<li>Critical Metals Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crml#NASDAQ">CRML</a>) fell 16.7% to $11.66.</li>
<li>Acorda Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) shares fell 12% to $2.20. Acorda Therapeutics shares dipped 81% on Tuesday after the company commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.</li>
<li>Exscientia plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exai#NASDAQ">EXAI</a>) fell 10.8% to $4.6395 following quarterly results.</li>
<li>Gamida Cell Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmda#NASDAQ">GMDA</a>) shares fell 8.4% to $0.0403 after gaining 18% on Tuesday.</li>
<li>e.l.f. Beauty, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/elf#NYSE">ELF</a>) fell 8.2% to $170.71 after peer Ulta Beauty reportedly issued weak guidance at a conference.</li>
<li>NWTN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwtn#NASDAQ">NWTN</a>) fell 8% to $7.21.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) shares tumbled 7.3% to $6.11 after gaining 8% on Tuesday.</li>
<li>Applied Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) fell 6.1% to $3.5850.</li>
<li>Lands&#39; End, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/le#NASDAQ">LE</a>) fell 6.1% to $11.25.</li>
<li>Intel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>) fell 6.1% to $41.27 after the company outlined a new financial framework for its foundry business. After the market close on Tuesday, Intel announced a new financial reporting structure designed to drive increased cost discipline and higher returns by providing greater transparency, accountability and incentives across the business.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38069445/ethereum-trades-below-3-400-following-adp-report-stacks-becomes-top-loser"> Ethereum Trades Below $3,400 Following ADP Report; Stacks Becomes Top Loser</a>

Penny Stocks

Small Cap

ABAT

ABIO

ACOR

ADXN

ANGH

APLD

ATAI

BCAN

BROG

CASA

CETY

CISS

CRML

CXAI

DXYZ

EGOX

ENVB

ESPR

EXAI

FGEN

GCTS

GMDA

INTC

Kintara Therapeutics, Inc. - Common Stock

KTRA

KYCH

LCFY

LGVC

MESO

MRNO

NWTN

Next Technology Holding Inc. - Ordinary Shares

NXTT

ONMD

PLAY

PYXS

SINT

SMTC

TCON

ULTA

VIEW

VNDA

VVPR

XTIA

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.
Shares of Signet Jewelers Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sig#NYSE">SIG</a>) rose sharply during Wednesday&rsquo;s session after the company <a href="https://www.benzinga.com/markets/equities/24/04/38068195/whats-going-on-with-signet-jewelers-stock-today">raised its FY25 guidance.</a>
The company and Leonard Green &amp; Partners, L.P., an equity investment firm, today announced the amendment of the terms of the Series A Convertible Preference Shares to net share settlement and the repurchase of half of the Preferred Shares. 
Signet increased its FY25 adjusted EPS outlook to $9.90 &ndash; $11.52 from $9.08 &ndash; $10.48 versus an estimate of $9.72.
Signet Jewelers shares surged 9.2% to $103.80 on Wednesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Destiny Tech100 Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NYSE">DXYZ</a>) shares jumped 21.4% to $25.77.</li>
<li>Ocugen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocgn#NASDAQ">OCGN</a>) shares gained 14.2% to $1.5750. HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterated Ocugen with a Buy and maintained a $7 price target.</li>
<li>Pyxis Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pyxs#NASDAQ">PYXS</a>) rose 12.3% to $6.04.</li>
<li>Atai Life Sciences N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atai#NASDAQ">ATAI</a>) climbed 11.4% to $2.08. Maxim Group analyst Jason McCarthy upgraded ATAI Life Sciences from Hold to Buy and announced a $6 price target.</li>
<li>SolarMax Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smxt#NASDAQ">SMXT</a>) rose 10.4% to $11.85.</li>
<li>Dave &amp; Buster&#39;s Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/play#NASDAQ">PLAY</a>) shares gained 10.2% to $68.22 after the company reported fourth quarter results.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) gained 9.7% to $3.16.</li>
<li>TransMedics Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmdx#NASDAQ">TMDX</a>) rose 9.2% to $79.47.</li>
<li>Porch Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prch#NASDAQ">PRCH</a>) gained 8.3% to $4.3450. Cantor Fitzgerald analyst Josh Siegler maintained Porch Group with an Overweight and raised the price target from $3 to $5.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zim#NYSE">ZIM</a>) gained 7.7% to $10.95.</li>
<li>Semtech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smtc#NASDAQ">SMTC</a>) climbed 7.4% to $30.28.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>) shares gained 6.8% to $62.88 after the company reported upbeat results for its fourth quarter.</li>
<li>Glaukos Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gkos#NYSE">GKOS</a>) rose 6.8% to $95.59. Glaukos received permanent J-code for iDose&reg; TR (travoprost intracameral implant).</li>
<li>Blue Owl Capital Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/owl#NYSE">OWL</a>) gained 6.4% to $19.69 after the company announced a purchase agreement to acquire Kuvare Insurance Services LP for $750 million.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) rose 6.3% to $23.88.</li>
<li>U.S. Silica Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slca#NYSE">SLCA</a>) gained 6.2% to $13.47.</li>
<li>Spotify Technology S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spot#NYSE">SPOT</a>) rose 5.6% to $284.61 on reports the company will raise monthly prices.</li>
<li>Arcadium Lithium plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/altm#NASDAQ">ALTM</a>) gained 4.8% to $4.34. Raymond James upgraded the stock from Outperform to Strong Buy and maintained its $9 price target.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38062892/how-to-earn-500-a-month-from-levi-strauss-stock-ahead-of-q1-earnings-report"> How To Earn $500 A Month From Levi Strauss Stock Ahead Of Q1 Earnings Report</a>

ALTM

GKOS

OCGN

PRCH

RILY

SLCA

SMXT

SPOT

TMDX

Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday

Stephens &amp; Co. analyst Ben Bienvenu reiterates Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) with a Equal-Weight and maintains $65 price target.

Reiteration

Stephens & Co. Reiterates Equal-Weight on Cal-Maine Foods, Maintains $65 Price Target

Shares of Cal-Maine Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>) rose sharply in today&rsquo;s pre-market trading after the company reported <a href="https://www.benzinga.com/news/earnings/24/04/38058699/cal-maine-foods-reports-better-than-expected-q3-results">upbeat results for its fourth quarter</a>.
The company reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.46 per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Cal-Maine Foods shares jumped 8.3% to $63.80 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>LAMF Global Ventures Corp. I (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvc#NASDAQ">LGVC</a>) rose 148.9% to $26.79 in pre-market trading. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd.</li>
<li>Aesthetic Medical International Holdings Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aih#NASDAQ">AIH</a>) gained 68.3% to $0.5389 in pre-market trading after gaining 13% on Tuesday.</li>
<li>OneMedNet Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onmd#NASDAQ">ONMD</a>) gained 34.1% to $1.06 in pre-market trading. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement of senior convertible notes.</li>
<li>Vanda Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnda#NASDAQ">VNDA</a>) shares gained 28.1% to $5.01 in pre-market trading. Vanda Pharmaceuticals&#39; Fanapt&reg; received U.S. FDA approval for the acute treatment of Bipolar I Disorder.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivp#NASDAQ">IVP</a>) gained 16% to $0.0545 in pre-market trading. On Jan. 5, Inspire Veterinary Partners filed a prospectus related to up to a $5 million public offering.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) shares rose 15.6% to $0.0473 in pre-market trading after gaining 13% on Tuesday. On March 26, C3is reported a year-over-year increase in fourth-quarter financial results.</li>
<li>Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) climbed 11.1% to $0.50 in pre-market trading after gaining around 3% on Tuesday.</li>
<li>Edible Garden AG Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edbl#NASDAQ">EDBL</a>) shares rose 9.2% to $0.3735 in pre-market trading. Edible Garden announced a reverse stock split of the company&#39;s common stock.</li>
<li>Dave &amp; Buster&#39;s Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/play#NASDAQ">PLAY</a>) shares rose 6.3% to $65.81 in pre-market trading after the company reported fourth quarter results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) declined 61.8% to $0.42 in pre-market trading after the company reached a real with Cantor Fitzgerald and RXR to become a private company.</li>
<li>Acorda Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) shares dropped 24% to $1.90 in pre-market trading. Acorda Therapeutics shares dipped 81% on Tuesday after the company commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.</li>
<li>HWH International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwh#NASDAQ">HWH</a>) fell 23.4% to $1.18 in pre-market trading after jumping 63% on Tuesday.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) fell 22.5% to $0.0324 in pre-market trading after gaining 5% on Tuesday. SiNtx Technologies recently announced a proposed public offering of common stock.</li>
<li>VivoPower International PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvpr#NASDAQ">VVPR</a>) fell 18.4% to $4.80 pre-market trading. VivoPower shares jumped 304% on Tuesday after the company&#39;s Tembo subsidiary announced it will merge with the Nasdaq-listed Cactus Acquisition Corp. 1 Limited.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) shares tumbled 13.1% to $5.73 in pre-market trading after gaining 8% on Tuesday.</li>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) fell 11.1% to $1.12 pre-market trading after dipping around 12% on Tuesday.</li>
<li>Gamida Cell Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmda#NASDAQ">GMDA</a>) shares fell 10% to $0.0396 in pre-market trading after gaining 18% on Tuesday.</li>
<li>Fractyl Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/guts#NASDAQ">GUTS</a>) fell 9.1% to $6.13 in pre-market trading after declining around 10% on Tuesday. The company recently announced FDA IDE approval for the Revita Remain-1 pivotal study and then rebounded after reporting Q4 financial results.</li>
<li>Intel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>) fell 4.8% to $41.85 in pre-market trading after the company outlined a new financial framework for its foundry business. After the market close on Tuesday, Intel announced a new financial reporting structure designed to drive increased cost discipline and higher returns by providing greater transparency, accountability and incentives across the business.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38062468/acuity-brands-likely-to-report-higher-q2-earnings-here-are-the-recent-forecast-changes-from-wall-st"> Acuity Brands Likely To Report Higher Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts</a>

EDBL

GUTS

MOTS

Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Cal-Maine Foods declares $1.02 dividend

The most frequently cited bullish chart on Slope is the indescribably boring Cal-Maine Foods (CALM​​​​​​​) which sells eggs, but by God, they must be good at it, because this sucker just keeps on cranking.

Remain Calm And Buy Eggs

Cal-Maine Foods: Better Than Expected Results, Cheap, And Growing

The 1-Minute Market Report October 6, 2024

Cal-Maine Foods announces expansion plans for additional cage-free production capabilities

CPI read: Food inflation steps up in September as eggs, butter, and beef prices jump

Catalyst Watch: Earnings blitz, Fed speakers, and notable healthcare conferences

Comments

Cal-Maine Foods

空売り

Cal-Maine Foods (NASDAQ:CALM) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル